Clinical Trial Update: Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Corewell Health West | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED